BioSpace News Archive

June 4, 2018 13:00 UTC Opdivo (nivolumab) 3 mg/kg Demonstrates Sustained, Superior Recurrence-Free Survival Versus Yervoy (ipilimumab) 10 mg/kg for Broad Range of Patients with Resected Stage III or IV Melanoma Opdivo is the only I-O therapy to demonstrate superiority versus an active control in this patient population Updated results represent longest follow-up of any PD-1 inhibitor in the adjuvant melanoma se

Merck KGaA, Darmstadt, Germany and Pfizer Inc. announced that updated efficacy and safety data from the pivotal JAVELIN Merkel 200 trial of BAVENCIO(R) (avelumab) in patients with metastatic Merkel cell carcinoma (mMCC), will be presented as an oral abstract session at the 54th American Society of Clinical Oncology (ASCO) Annual Meeting.

OncoSec Medical Incorporated announced the presentation of a Trials in Progress poster at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting taking place in Chicago, IL.

Scientists working in metabolomics, pharmaceuticals, food safety, and environmental and forensic science can now use a fully integrated software toolkit to transform complex, unknown mass spectra generated from small molecule analysis into actionable data.

Analytical scientists facing the challenges of quantitation in food and environmental applications can now achieve high productivity and meet laboratory demands with a fast yet robust mass spectrometer.

Eiger BioPharmaceuticals, Inc. announced that an oral presentation from the Phase 2 LOWR HDV (LOnafarnib With Ritonavir in Hepatitis Delta Virus) Program as well as an update on the Phase 3 D-LIVR study will be presented at Global Hepatitis Summit 2018™.

AOBiome Therapeutics announced the election of Jun Wang, Ph.D., founder and CEO of iCarbonX, as Chairman of AOBiome’s Board of Directors, effective May 31, 2018.

Laboratory for Advanced Medicine (LAM) announced that Justin Li, General Manager and Vice President of Finance, will present at the 2018 BIO International Convention.

The Jed Foundation (JED) will host their 17th Annual Gala tonight, Monday June 4th at Cipriani Wall Street.

Kelyniam Global, Inc. has issued a letter to shareholders and published financials for 2015, 2016 and 2017.